Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Foliglurax monohydrochloride Antiparkinsonian effect. is a highly selective and potent, brain-penetrant metabotropic glutamate receptor 4 positive allosteric modulator (mGluR4 PAM) , with an EC50 of 79 nM.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 約6-8 週間 | ¥ 98,000 |
25 mg | 約6-8 週間 | ¥ 305,500 |
50 mg | 約6-8 週間 | ¥ 399,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | Foliglurax monohydrochloride Antiparkinsonian effect. is a highly selective and potent, brain-penetrant metabotropic glutamate receptor 4 positive allosteric modulator (mGluR4 PAM) , with an EC50 of 79 nM. |
ターゲット&IC50 | mGlu4:79 nM (EC50) |
In vitro | Foliglurax, might revolutionize the field of mGlu4 receptor drug targeting in CNS disorders.a highly selective and potent mGlu4 receptor PAM with a marked brain-penetrance feature. |
別名 | PXT002331 (monohydrochloride) |
分子量 | 457.97 |
分子式 | C23H24ClN3O3S |
CAS No. | 2133294-96-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/mL (10.92 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Foliglurax monohydrochloride 2133294-96-7 Others Foliglurax PXT002331 PXT-002331 Foliglurax Monohydrochloride PXT002331 (monohydrochloride) PXT 002331 Inhibitor inhibitor inhibit